These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16634362)

  • 1. Atherogenesis in rheumatology.
    van Leuven SI; Kastelein JJ; D'Cruz DP; Hughes GR; Stroes ES
    Lupus; 2006; 15(3):117-21. PubMed ID: 16634362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
    Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
    Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.
    Zeller CB; Appenzeller S
    Curr Cardiol Rev; 2008 May; 4(2):116-22. PubMed ID: 19936286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Salmon JE; Roman MJ
    Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
    Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
    Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
    Cederholm A; Frostegård J
    Immunobiology; 2005; 210(10):761-8. PubMed ID: 16325495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
    Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
    Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
    Kahlenberg JM; Kaplan MJ
    Annu Rev Med; 2013; 64():249-63. PubMed ID: 23020882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Torres-Granados C; Aguirre-Zamorano MA; Collantes-Estevez E; Pérez-Sánchez C
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.
    Lopez-Pedrera C; Aguirre-Zamorano MÁ; Pérez-Sánchez C
    Med Clin (Barc); 2017 Aug; 149(4):160-169. PubMed ID: 28619369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation as a risk factor for atherothrombosis.
    van Leuven SI; Franssen R; Kastelein JJ; Levi M; Stroes ES; Tak PP
    Rheumatology (Oxford); 2008 Jan; 47(1):3-7. PubMed ID: 17702769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.